High dose dipyridamole myocardial imaging: Simultaneous sestamibi scintigraphy and two-dimensional echocardiography in the detection and evaluation of coronary artery disease

Coronary Artery Disease

Volumn 10, Issue 3, 1999, Pages 177-184

  Parodi, Guido ^a,b   Picano, Eugenio ^a,b   Marcassa, Claudio ^c   Sicari, Rosa ^a,b   Marzullo, Paolo ^a,b   Verna, Edoardo ^d   Bisi, Gianni ^e   Galli, Michele ^c   Pirelli, Salvatore ^e   Inglese, Eugenio ^e   Parodi, Oberdan ^a,b   Sambuceti, Gianmario ^a,b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b CNR   (Italy)

^c Fondazione Clinica del Lavoro   (Italy)

^d OSPEDALE DI CIRCOLO   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Coronary artery disease; Dipyridamole; Perfusion scintigraphy; Stress echocardiography

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SCINTIGRAPHY; STATISTICAL ANALYSIS; STRESS ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0033049925     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199905000-00007     Document Type: Article

References (36)

1. 1 Picano E. Dipyridamole-echocardiography test: historical background and physiologic basis. Eur Heart J 1989; 10:365-376.
2. 2 Gould KL. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. I. Physiologic basis and experimental validation. Am J Cardiol 1978; 41:267-277.
3. 3 Gould KL, Westcott JR, Albro PC, Hamilton GW. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. II. Clinical methodology and feasibility. Am J Cardiol 1978; 41:279-287.
4. 4 Picano E, Distante A, Masini M, Morales MA, Lattanzi F, L'Abbate A. Dipyridamole-echocardiography test in effort angina pectoris. Am J Cardiol 1985; 56:452-456.
5. 5 Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986; 8:848-854.
6. 6 Wackers FJ, Soufer R, Zaret BL. Nuclear cardiology. In: Braunwald E (editor): Heart disease. A textbook of cardiovascular medicine. Philadelphia: WB Saunders; 1997. pp 273-316.
7. 7 Wackers JT. Which pharmacological stress is optimal? Circulation 1993; 87:646-648.
8. 8 Botvinick EH. A consideration of current clinical options for stress imaging in the diagnosis and evaluation of coronary artery disease. J Nucl Cardiol 1994; 1 (suppl 1):S147-S170.
9. 9 Parodi O, Marcassa C, Casucci R, Sambuceti G, Verna E, Galli M, et al. Accuracy and safety of technetium-99m hexakis 2-methoxy-2isobutyl isonitrile (sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: a multicenter study. J Am Coll Cardiol 1991; 17:879-886.
10. 10 Picano E, Landi P, Bolognose L, Chiarandà G, Chiarella F, Seveso G, et al. on behalf of the EPIC study group. The prognostic value of dipyridamole-echocardiography early after uncomplicated myocardial infarction: a large scale multicenter study. Am J Med 1993; 95:608-618.
11. 11 Picano E, Lattanzi F, Orlandini A, Marini C, L'Abbate A. Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol 1991; 17:666-669.
12. 12 Pepine CJ. Coronary angiography and cardiac catheterization. In: Topol EJ (editor): Textbook of cardiovascular medicine. Philadelphia: Lippincott-Raven; 1998. pp. 1935-1956.
13. 13 Mark DB, Nelson CL, Califf RM, Harrell FE, Lee KL, Jones RH, et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation 1994; 89:2015-2025.
14. 14 Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms: recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echo 1989; 2:358-367.
15. 15 Flameng W, Wusten B, Schaper W. On the distribution of myocardial blood flow. Effects of arterial stenosis and vasodilation. Basic Res Cardiol 1974; 69:435-446.
16. 16 Ross J Jr. Mechanism of regional ischemia and antianginal drug action during exercise. Prog Cardiovasc Dis 1989; 31:456-466.
17. 17 Fung AY, Gallagher KP, Buda AJ. The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation 1987; 16:1375-1383.
18. 18 Picano E. Stress echocardiography. 3rd Edition. Heidelberg: Springer Verlag; 1997.
19. 19 Perin EC, Moore W, Blume M, Hernandes G, Dhekne R, DeCastro CM. Comparison of dipyridamole echocardiography with dipyridamole thallium scintigraphy for the diagnosis of myocardial ischemia. Clin Nucl Med 1991; 16:417-420.
20. 20 Ferrara N, Bonaduce D, Leosco D, Longobardi G, Abete P, Morgano G, et al. Two-dimensional echocardiographic evaluation of ventricular asynergy induced by dipyridamole: correlation with thallium scanning. Clin Cardiol 1986; 9:437-442.
21. 21 Schillaci O, Moroni C, Scopinaro F, Tavolaro R, Danieli R, Bossini A, et al. Technetium-99m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain. Eur J Nucl Med 1997; 24:774-778.
22. 22 Santoro GM, Sciagrà R, Bounamici P, Consoli N, Mazzoni V, Zerauscheck F, et al. Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease. J Nucl Cardiol 1998; 5:19-27.
23. 23 Labovitz AJ, Pearson AC, Chaitman BR. Doppler and two-dimensional echocardiographic assessment of left ventricular function before and after intravenous dipyridamole stress testing for detection of coronary artery disease. Am J Cardiol 1988; 62:1180-1185.
24. 24 Jain A, Suarez J, Mahmarian JJ, Zoghbi WA, Quinones MA, Verani M. Functional significance of myocardial perfusion defects induced by dipyridamole using thallium-201 single-photon emission computed tomography and two-dimensional echocardiography. Am J Cardiol 1990; 66:802-806.
25. 25 Zoghbi WA. Use of adenosine echocardiography for diagnosis of coronary artery disease. Am Heart J 1991; 122:285-292.
26. 26 Takeishi Y, Chiba J, Abe S, Yamaki M, Tomoike H. Adenosine-induced heterogeneous perfusion accompanies myocardial ischemia in the presence of advanced coronary artery disease. Am Heart J 1994; 127:1262-1268.
27. 27 Marwick T, Willemart B, D'Hondt AM, Baudhuin T, Wijns W, Detry JM, et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion: comparison of dobutamine and adenosine using echocardiography and Tc-99m-MIBI single photon emission computed tomography. Circulation 1993; 87:345-354.
28. 28 Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR. Comparison of adenosine, dipyridamole, dobutamine in stress echocardiography. Ann Int Med 1992; 116:190-196.
29. 29 Lalonde D, Taillefer R, Lambert R, Bisson G, Basile F, Prieto I, et al. Thallium-201 -dipyridamole imaging: comparison between a standard dose and a high dose of dipyridamole in the detection of coronary artery disease. J Nucl Med 1994; 35:1245-1253.
30. 30 Casanova R, Petroncini A, Guidotti PL, Capacci PF, Jacopi F, Fabbri M, et al. Dose and test for dipyridamole infusion and cardiac imaging early after uncomplicated acute myocardial infarction. Am J Cardiol 1992; 70:1402-1406.
31. 31 Hutchinson SJ, Shen A, Soldo S, Hla A, Kawanishi DT, Chandraratna AN. Transesophageal assessment of coronary flow velocity reserve during 'regular' and 'high'-dose dipyridamole stress testing. Am J Cardiol 1996; 77:1164-1168.
32. 32 McNeill AJ, Fioretti PM, El-Said EM, Salustri A, Forster T, Roeland JR. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992; 70:41-46.
33. 33 Kiat H, Maddahi J, Roy LT, Friedman J, Resser K, Berman DS. Comparison of technetium-99m methoxy isobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989; 117:1-11.
34. 34 Castini D, Gentile F, Ornaghi M, Montani E, Lippolis A, Mangiarotti E, et al. Dobutamine echocardiography: usefulness of digital image processing. Eur Heart J 1995; 16:1420-1424.
35. 35 Pingitore A, Picano E, Quartacolosso M, Reisenhofer B, Gigli G, Lucarini AR, et al. The atropine factor in pharmacological stress echocardiography. J Am Coll Cardiol 1996; 27:1164-1170.
36. 36 Picano E. Stress echocardiography: from pathophysiological toy to diagnostic tool. Point of view. Circulation 1992; 85:1604-1612.